All Type of News
SCD Pharm signs total KRW 700 billion export agreement with U.S. Glenmark
Sam Chun Dang Pharm(CEO Jeon-Kyo Park, SCD Pharm) signed a export agreement of its generic eye drop with U.S. Glenmark on the 20th. The export agreement is the 2nd largest export agreement after the last KRW 400 billi...
Rapid increase of bioequivalently proven medicines, what is the reason?
The number of medicines bioequivalently proven this year was 157 products, reportedly increased by 58%.
The phenomenon was caused by the fact the Korean pharmaceutical companies have been active in developing generic...
Rapid increase of bioequivalently proven medicines, what is the reason?
The number of medicines bioequivalently proven this year was 157 products, reportedly increased by 58%.
The phenomenon was caused by the fact the Korean pharmaceutical companies have been active in developing generic...
Most incrementally modified drugs approved last year were antihypertensives with 7 products
Just like new drugs, incrementally modified drugs that are being developed by Korean pharmaceutical companies are also experiencing a drought as well.
According to the Ministry of Food and Drug Safety, there were 11 ...
Kolmar Korea to bring an upheaval in pharma industry with acquisition of CJ HealthCare
Kolmar Korea, a global cosmetic ODM(Original Design Manufacturer) company and the top CMO(Contract Manufacturing Organization) in Korea, will acquire the pharmaceutical company under CJ Group, CJ HealthCare. The acqui...
“Pharmacies with less than 5 employees must follow rules about minimum wage and retirement pension”
It was requested to definitely follow the minimum wage, holiday benefits and retirement pension not to cause any trouble in pharmacies with less than 5 employees.
It was also stressed it would be important to fully u...
Pouring generic approval of ‘Dexid Tab’ generics, will enlarge market of diabetic neuropathy therapies?
Dexid Tab, a diabetic neuropathy therapy, were reportedly referenced by more than 40 generic drugs to acquire approval.
The market size of Dexid Tab is calculated at approximately KRW 10 billion, but it seems it will...
Hanmi Pharm’s new oral anticancer drug ‘Oraxol starts global Phase III clinical trial
They will actively start the global Phase III clinical trial of Oraxol, an oral anticancer drug developed by Hanmi Pharm.
A Hanmi Pharm’s partner, Athenex(Nasdaq: ATNX) announced that the company completed the Phase ...
Celltrion proves equivalent effect on Remsima, Remicade and Humira
At the 2018 European Crohn’s and Colitis Organisastion(ECCO) held in Vienna, Austria, large clinical study results on Crohn’s disease patients were revealed.
In these studies, the remission rate of each patient group...
Pharmaceutical industry caught two hares at once
While recording a huge growth both in quality and quantity with 32% increased employees only in 10 years, the Korean pharmaceutical industry was analyzed to have a bright future ahead as having increases in all the ca...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
